Scarica l'app Stockscreener
37.08
1.42%
0.52
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$36.56
Aprire:
$37.06
Volume 24 ore:
268.93K
Relative Volume:
0.50
Capitalizzazione di mercato:
$1.14B
Reddito:
$1.37B
Utile/perdita netta:
$47.06M
Rapporto P/E:
24.47
EPS:
1.5151
Flusso di cassa netto:
$150.88M
1 W Prestazione:
+1.01%
1M Prestazione:
-19.36%
6M Prestazione:
-19.37%
1 anno Prestazione:
-37.87%
Intervallo 1D:
$36.11
$37.25
Intervallo di 1 settimana:
$35.67
$37.58
Portata 52W:
$35.37
$61.25
Conmed Corp Stock (CNMD) Company Profile
Nome
Conmed Corp
Settore
Industria
Telefono
727-214-2974
Indirizzo
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
37.08 | 1.14B | 1.37B | 47.06M | 150.88M | 1.5151 |
ABT
Abbott Laboratories
|
104.83 | 182.16B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.39B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 112.84B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 103.71B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 48.01B | 6.07B | 1.06B | 1.34B | 1.8063 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-17 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-06-12 | Downgrade | Needham | Buy → Hold |
| 2025-04-28 | Downgrade | Stifel | Buy → Hold |
| 2025-02-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-02-01 | Reiterato | Needham | Buy |
| 2023-05-22 | Iniziato | CL King | Buy |
| 2023-03-27 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | Iniziato | Wells Fargo | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-10-06 | Aggiornamento | Needham | Hold → Buy |
| 2021-07-15 | Iniziato | UBS | Buy |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2019-11-26 | Downgrade | Needham | Buy → Hold |
| 2019-11-12 | Iniziato | JP Morgan | Overweight |
| 2019-10-31 | Reiterato | Needham | Buy |
| 2019-10-04 | Reiterato | Needham | Buy |
| 2019-08-22 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | Iniziato | Stifel | Buy |
| 2019-04-16 | Reiterato | Needham | Buy |
| 2019-01-23 | Reiterato | Needham | Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-08-07 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-04-26 | Reiterato | Needham | Buy |
| 2018-02-01 | Reiterato | Needham | Buy |
| 2017-07-27 | Reiterato | Needham | Buy |
| 2017-04-27 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | Reiterato | Needham | Buy |
| 2016-11-18 | Reiterato | Needham | Buy |
| 2016-07-28 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | Reiterato | Needham | Buy |
| 2015-10-22 | Reiterato | Northland Capital | Market Perform |
Mostra tutto
Conmed Corp Borsa (CNMD) Ultime notizie
Tudor Investment Corp ET AL Acquires 83,418 Shares of CONMED Corporation $CNMD - MarketBeat
Movement Recap: Can CONMED Corporation sustain its profitability2026 Technical Patterns & AI Powered Market Entry Strategies - baoquankhu1.vn
CONMED (NYSE:CNMD) Strengthens Role In Nyse Composite Landscape - Kalkine Media
Is It Time To Reassess CONMED (CNMD) After A 39% One Year Share Price Slide - simplywall.st
Market Pulse: Is CONMED Corporation likely to announce a buyback2026 Breakouts & High Accuracy Investment Signals - baoquankhu1.vn
Confluence Investment Management LLC Has $3.70 Million Stake in CONMED Corporation $CNMD - MarketBeat
Conmed (NYSE:CNMD) Portfolio Changes Reflect Broader Market Trends Nyse Composite Today - Kalkine Media
CONMED (NYSE:CNMD) Stock Rating Upgraded by Wells Fargo & Company - Defense World
Micro-Tech Endoscopy to acquire Conmed gastroenterology products - MassDevice
Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Alto Neuroscience, Inc. (ANRO) and Pfizer (PFE) - The Globe and Mail
CONMED (NYSE:CNMD) Upgraded to "Hold" at Wells Fargo & Company - MarketBeat
CONMED (NYSE: CNMD) EVP granted 17,198 RSUs after award correction - Stock Titan
CONMED (NYSE: CNMD) VP granted 17,471 RSUs under 2025 incentive plan - Stock Titan
CONMED (CNMD) grants 18,563 RSUs to its general counsel Foust - Stock Titan
Executive VP at CONMED (CNMD) awarded 16,926 RSUs in corrected Form 4/A - Stock Titan
[Form 4/A] CONMED Corp Amended Insider Trading Activity - Stock Titan
Micro-Tech Endoscopy Signs Definitive Agreement to Acquire Duraclip™, Precisor®, and Optibite® Product Lines from CONMED - Yahoo! Finance Canada
Piper Sandler cuts CONMED stock rating on execution issues - Investing.com
Understanding the Setup: (CNMD) and Scalable Risk - Stock Traders Daily
Here's why you should retain CONMED stock in your portfolio now - MSN
CONMED (NYSE: CNMD) appoints Andrew Moller interim principal financial officer - Stock Titan
CONMED (CNMD) executive exercises RSUs and updates reported share holdings - Stock Titan
Here's Why You Should Retain CONMED Stock in Your Portfolio Now - Finviz
CONMED Corp. Experiences Valuation Adjustment Amidst Competitive Market Dynamics - Markets Mojo
CONMED Corp. Experiences Valuation Adjustment Amid Competitive Market Landscape - Markets Mojo
CONMED (NYSE:CNMD) Raised to Strong-Buy at Wall Street Zen - MarketBeat
Pharma News: What hedge funds are buying CONMED Corporation2025 Momentum Check & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know - Yahoo Finance
The Technical Signals Behind (CNMD) That Institutions Follow - Stock Traders Daily
Equity awards for CONMED (CNMD) VP Matthew Schabacker detailed in Form 4 - Stock Titan
CONMED (CNMD) HR executive awarded RSUs and stock options under 2025 plan - Stock Titan
CONMED Corp (NYSE: CNMD) treasurer awarded 5,896 RSUs - Stock Titan
CONMED (NYSE: CNMD) grants RSUs and stock options to EVP - Stock Titan
CONMED (NYSE: CNMD) EVP granted RSUs and stock options in 2026 award - Stock Titan
Equity awards granted to CONMED (CNMD) General Counsel Hollie Foust - Stock Titan
Equity grant: CONMED (CNMD) VP Corporate Controller receives 5,896 RSUs - Stock Titan
CONMED Earnings Reset Story After Strong Quarter And Higher Guidance - Yahoo Finance
CNMD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
3 Reasons CNMD is Risky and 1 Stock to Buy Instead - Yahoo Finance
Conmed (CNMD) Up 22.9% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Assessing CONMED (CNMD) Valuation After Mixed Short And Long Term Share Price Performance - simplywall.st
Director Mark Kaye converts 152 RSUs at CONMED (NYSE: CNMD) into stock - Stock Titan
Momentum Shift: Does CONMED Corporation have declining or rising EPSMarket Activity Report & Precise Swing Trade Alerts - baoquankhu1.vn
Villanova Investment Management Co LLC Acquires New Shares in CONMED Corporation $CNMD - MarketBeat
Precision Trading with Conmed Corp.Ordinary Shares (CNMD) Risk Zones - Stock Traders Daily
CONMED (NYSE:CNMD) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Envestnet Asset Management Inc. Boosts Holdings in CONMED Corporation $CNMD - Defense World
Decoding Conmed Corp (CNMD): A Strategic SWOT Insight - GuruFocus
CONMED Corp SEC 10-K Report - TradingView
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now - Finviz
CONMED (NYSE:CNMD) Upgraded at Zacks Research - Defense World
Conmed Corp Azioni (CNMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):